| Ticker Details |
|
PDS Biotechnology Corporation
|
| IPO Date: |
October 2, 2015 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$12.23M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.20 | 4.86%
|
| Avg Daily Range (30 D): |
$0.04 | 5.91%
|
| Avg Daily Range (90 D): |
$0.06 | 6.19%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.65M |
| Avg Daily Volume (30 D): |
1.67M |
| Avg Daily Volume (90 D): |
1.14M |
| Trade Size |
| Avg Trade Size (Sh.): |
209 |
| Avg Trade Size (Sh.) (30 D): |
635 |
| Avg Trade Size (Sh.) (90 D): |
423 |
| Institutional Trades |
| Total Institutional Trades: |
26 |
| Avg Institutional Trade: |
$1.98M |
| Avg Institutional Trade (30 D): |
$1.59M |
| Avg Institutional Trade (90 D): |
$1.59M |
| Avg Institutional Trade Volume: |
.42M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.99M |
| Avg Closing Trade (30 D): |
$.72M |
| Avg Closing Trade (90 D): |
$.72M |
| Avg Closing Volume: |
791.96K |
|
|
| Financials |
| |
TTM |
Q2 2026 |
Q1 2026 |
|
Basic EPS
|
$-.64
|
$-.18
|
$-.13
|
|
Diluted EPS
|
$-.64
|
$-.18
|
$-.13
|
|
Revenue
|
$M
|
$M
|
$M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-33.67M
|
$-9.75M
|
$-7.35M
|
|
Operating Income / Loss
|
$-27.83M
|
$-6.5M
|
$-6.52M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$M
|
$M
|
$M
|
|
PE Ratio
|
|
|
|
|
|
|